Connection

PEDRO PIEDRA to Viral Vaccines

This is a "connection" page, showing publications PEDRO PIEDRA has written about Viral Vaccines.
Connection Strength

1.409
  1. A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. J Infect Dis. 2016 Feb 01; 213(3):411-22.
    View in: PubMed
    Score: 0.388
  2. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antiviral Res. 2005 Apr; 66(1):57-66.
    View in: PubMed
    Score: 0.189
  3. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
    View in: PubMed
    Score: 0.167
  4. Clinical experience with respiratory syncytial virus vaccines. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S94-9.
    View in: PubMed
    Score: 0.163
  5. Maternal immunization against viral disease. Vaccine. 1998 Aug-Sep; 16(14-15):1456-63.
    View in: PubMed
    Score: 0.119
  6. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Pediatr Infect Dis J. 1998 Mar; 17(3):217-24.
    View in: PubMed
    Score: 0.116
  7. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine. 1995 Aug; 13(12):1095-101.
    View in: PubMed
    Score: 0.097
  8. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 1993 Nov; 11(14):1415-23.
    View in: PubMed
    Score: 0.086
  9. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J. 2004 Nov; 23(11 Suppl):S254-61.
    View in: PubMed
    Score: 0.046
  10. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
    View in: PubMed
    Score: 0.025
  11. Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease. J Gen Virol. 1989 Feb; 70 ( Pt 2):325-33.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.